Changes in metabolic syndrome parameters in patients with schizoaffective disorder who participated in a randomized, placebo-controlled trial of topiramate
To access this article, please choose from the options below
PII: S1876-2018(09)00063-X
doi:10.1016/j.ajp.2009.08.006
© 2009 Elsevier B.V. All rights reserved.
